ART MEDICAL Ltd is a medical technology company dedicated to enhancing patient care in Intensive Care Units (ICUs). They specialize in developing and providing intelligent solutions, including sensor-based Smart Tubes and comprehensive Patient Data Management systems. These technologies are designed to prevent common ICU complications like aspiration pneumonia, reduce the risk of hospital-acquired infections, automate routine tasks to lessen manual labor for medical staff, and ultimately save costs for healthcare facilities. By collecting and analyzing real-time patient data, ART MEDICAL's systems offer actionable insights and alerts to caregivers, aiming to significantly improve patient safety and outcomes.
The Caesarea headquarters serves as the central hub for research and development, product innovation, engineering, corporate strategy, and global operations management for ART MEDICAL's ICU solutions.
Located in Caesarea, which houses a prominent industrial and business park (Caesarea Business Park), known for attracting high-tech and medical device companies. The specific building features are not publicly detailed, but it's part of a modern tech ecosystem.
As a medical technology company focused on innovation in critical care, the work culture likely emphasizes precision, collaboration between engineering and medical experts, rigorous testing, problem-solving, and a profound commitment to improving patient outcomes. It fosters a dynamic and challenging environment for research and development.
The headquarters in Israel is significant as it positions ART MEDICAL within a globally recognized hub for technological innovation, particularly in the medical device sector. It's the birthplace of their core technologies and strategic direction, benefiting from the local talent pool and R&D ecosystem.
ART MEDICAL Ltd operates with a global outlook, driven from its headquarters in Israel and supported by its U.S. office in Princeton, New Jersey. Key functions supported globally include cutting-edge research and development of ICU medical devices, manufacturing and supply chain management, international sales and marketing strategies, clinical education and support for its smART+™ platform, and establishing strategic partnerships with healthcare institutions and distributors worldwide to enhance critical patient care and introduce its innovative technologies to new markets.
HaEshel St 7
Caesarea
Haifa District
Israel
Address: 100 Overlook Center, 2nd Floor, Princeton, NJ 08540, USA
To expand market presence in the United States, provide localized support for U.S. clients and partners, manage clinical trials and regulatory submissions, and adapt product offerings to meet the specific needs of the North American healthcare system.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ART MEDICAL Ltd.' leadership includes:
ART MEDICAL Ltd. has been backed by several prominent investors over the years, including:
No major publicly announced executive new hires or exits have been identified for ART MEDICAL Ltd in the last 12 months through general news channels. Changes in leadership at private companies of this size are often not widely publicized unless they are of significant strategic importance or part of regulatory filings.
Discover the tools ART MEDICAL Ltd. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ART MEDICAL Ltd's precise email format is not publicly confirmed. However, common corporate email patterns for technology companies include [first_initial][last] (e.g., jdoe@artmedical.com) or [first] (e.g., john@artmedical.com). The general contact email is info@artmedical.com.
[first]@artmedical.com or [first_initial][last]@artmedical.com
Format
liron@artmedical.com
Example
70%
Success rate
CISION PR Newswire • July 19, 2023
ART MEDICAL Ltd received FDA 510(k) clearance for its smART+™ Enteral Feeding System, which incorporates AI for automated detection of lung infiltrates. This clearance allows the commercialization of the system in the U.S., aiming to improve patient safety during enteral feeding in ICUs by helping to prevent aspiration....more
Medgadget • October 25, 2023
ART MEDICAL showcased its smART+ platform for comprehensive feeding tube management at the European Society of Intensive Care Medicine (ESICM) LIVES 2023 congress. The presentation emphasized the platform's capabilities in preventing aspiration pneumonia and optimizing nutritional therapy for critically ill patients in ICUs....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ART MEDICAL Ltd., are just a search away.